7-APB
| Clinical data | |
|---|---|
| Other names | 7-(2-Aminopropyl)benzofuran; 7-APB |
| Drug class | Serotonin–norepinephrine–dopamine releasing agent (SNDRA) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H13NO |
| Molar mass | 175.231 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
7-(2-Aminopropyl)benzofuran (7-APB) is a monoamine releasing agent and designer drug of the benzofuran family, albeit with a potency an order of magnitude less than 6-APB. It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA). The drug was detected as a novel designer drug, in Europe, by 2013.